癌症相關科系

細胞治療中心的依據指引

14 個學習主題共依據 14 份臨床指引與文獻。點主題名稱看它的學習重點。

CAR-T細胞治療原理1 份

  1. Tracing the development of CAR-T cell design: from concept to next-generation platforms|Frontiers in Immunology|2025
    Alsaieedi AA, Zaher KA · DOI · CC BY 4.0

CAR-T適應症與病人篩選1 份

  1. Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations|Bone Marrow Transplantation|2025
    Greco R, Ruggeri A, McLornan DP, et al. · DOI · CC BY-NC-ND 4.0

白血球分離術1 份

  1. Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL|Cells|2020
    Korell F, Laier S, Sauer S, et al. · DOI · CC BY 4.0

細胞製備與品質管制1 份

  1. A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactors|Frontiers in Immunology|2024
    Hood T, Slingsby F, Sandner V, et al. · DOI · CC BY 4.0

橋接治療與淋巴清除化療1 份

  1. Lymphodepletion chemotherapy in CAR-T cell therapy in lymphoma|Bone Marrow Transplantation|2025
    Canelo-Vilaseca M, Sabbah M, Di Blasi R, et al. · DOI · CC BY-NC-ND 4.0

CAR-T輸注流程1 份

  1. The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy|EBMT|2022
    EBMT的全部指引 · Ellard R, Kenyon M, Hutt D, et al. · DOI · CC BY 4.0

細胞激素釋放症候群分級與處置1 份

  1. Latest updates on pathogenesis and management for CRS, neurotoxicity, and HLH related to CAR-T|Annals of Hematology|2025
    Wang X, He X, Zhang T, et al. · DOI · CC BY 4.0

免疫效應細胞相關神經毒性1 份

  1. ICANS following CAR T-cell therapy: a review of recent advances|J Translational Medicine|2026
    Fatahichegeni M, Ansarian MA, Wang Y, et al. · DOI · CC BY-NC-ND 4.0

腫瘤浸潤淋巴球與自然殺手細胞治療1 份

  1. Recent advances in adoptive cell therapy for cancer immunotherapy(TIL/NK/CAR-NK)|Frontiers in Immunology|2025
    Qian J, Liu Y · DOI · CC BY 4.0

樹突細胞疫苗1 份

  1. Research progress on dendritic cell vaccines in cancer immunotherapy|Exp Hematol & Oncol|2022
    Yu J, Sun H, Cao W, et al. · DOI · CC BY 4.0

細胞治療長期追蹤1 份

  1. Data-informed optimization of CAR T-cell therapy long-term follow-up (position article and guidelines)|J Immunother Cancer|2026
    Foss-Campbell B, Myers N, Awasthi R, et al. · DOI · CC BY-NC 4.0

細胞治療法規與特管辦法1 份

  1. Pathing the way from regulatory approval to market access for gene therapy products (US/EU5/Japan/China)|Regenerative Therapy|2026
    Shi J, Hu H, Ung COL · DOI · CC BY-NC-ND 4.0

再生醫療品質與優良操作規範1 份

  1. Implementation of a quality management system for decentralized manufacturing of cell and gene therapy products|Frontiers in Medicine|2025
    von der Leyen H, Delgado J, Mazouz C, et al. · DOI · CC BY 4.0

輸注後感染與B細胞缺乏處置1 份

  1. ASTCT Best Practice Considerations: Infection Prevention and Management After CAR T Cell Therapy|ASTCT|2024
    Shahid Z, Jain T, Dioverti V, et al. · DOI · CC BY 4.0

使用 Google 帳號登入,第一次登入時選擇科別即可開始;已經在用?直接登入